Table 1.

Patient disposition

	n (%)
Enrolled	209 (100)
Evaluable at enrolment	209 (100)
Performed V2 (3 ± 1.5 months)	191 (91.4)
Performed V3 (6 ± 1.5 months)	172 (82.3)
Performed V4 (9 ± 1.5 months)	161 (77.0)
Performed V5 (12 ± 1.5 months)	174 (83.3)
Withdrawn patients	36 (17.2)
Inclusion in clinical trial	1 (0.5)
Consent withdrawal (from patient or legally accepted representative)	3 (1.4)
Lost to follow-up	19 (9.1)
Death	13 (6.2)
Other cause of discontinuation	1 (0.5)

The mean (± SD) number of months between baseline and follow-up visits was 3.24 (± 0.58) months for V2 follow-up, 6.26 (± 0.58) months for V3 follow-up, 9.16 (± 0.61) months for V4 follow-up, and 12.32 (± 0.66) months for V5 follow-up

SD standard deviation, V Visit